Differential effects of cyclic adenosine 3′, 5′‐monophosphate on T cell cytotoxicity
- 1 September 1994
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 24 (9) , 2150-2154
- https://doi.org/10.1002/eji.1830240932
Abstract
We have investigated natural killer cell and T cell cytotoxicity using different assays and report a dual effect of cyclic adenosine 3′, 5′‐monophosphate (cAMP) on T cell cytotoxicity depending on the activation status of the effector cell and the test system in question. cAMP enhanced the capacity of pre‐activated T cells to induce DNA fragmentation in the target cell, while it inhibited spontaneous T cell cytotoxicity and natural killer cell cytotoxicity in conventional assays based on 51Cr release. The enhancement was most likely mediated by the cAMP‐dependent protein kinase type II (cAKII), which is the particular isoform in T cells associated with the centrosome and the microtubule organizing center (MTOC). We show the complete co‐localization of the cAKII with the centrosome after conjugate formation. Furthermore, the reorganization of the MTOC following conjugate formation brings the type II kinase into close proximity with the T lymphocyte membrane area engaged in the effector‐target interaction. Functional studies utilizing different cAMP‐analog combinations further substantiate the involvement of the type II kinase.Keywords
This publication has 26 references indexed in Scilit:
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.Gut, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Signal transduction events leading to T-cell lymphokine gene expressionImmunology Today, 1993
- Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.The Journal of Experimental Medicine, 1993
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- Microtubule Organizing CentersAnnual Review of Cell Biology, 1985
- Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combinationEuropean Journal of Biochemistry, 1985
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982